Oncology
On December 13, 2024, FDA officials approved cosibelimab-ipdl (Unloxcyt; Checkpoint Therapeutics, Inc.), a programmed death ligand-1 (PD-L1) blocking antibody, for adults with locally advanced CSCC (laCSCC) who are not candidates for curative surgery or curative radiation or metastatic cutaneous squamous cell carcinoma (mCSCC). Read More ›
Patients diagnosed with major diseases, including cancer, often experience financial hardship due to high out-of-pocket medical costs in the United States. Read More ›
Increased access to broadband usage was associated with earlier-stage non-small cell lung cancer (NSCLC) diagnosis and with receiving guideline-concordant care in 2020, during the height of the COVID-19 pandemic. Read More ›
Pancreatic cancer is a devastating diagnosis, with a high mortality rate and few effective treatment options. For many veterans, the risk of developing pancreatic cancer may be linked to exposure to Agent Orange, a chemical herbicide widely used during the Vietnam War. Read More ›
There is a link between toxic exposures during military service and the prevalence of lung cancer among veterans, according to a study presented at the International Association for the Study of Lung Cancer (IASLC)’s 2024 World Conference on Lung Cancer, held recently in San Diego, California. Read More ›
People are generally more positive about the perception and frequency of biomarker testing than an earlier survey conducted in 2018, but barriers remain, according to results from a recently released survey. Read More ›
In the course of carrying out their duties, US military personnel face numerous hazards. Although the risks of combat are widely recognized, there are other lesser-known dangers that can have significant, long-lasting impacts on the health of those who serve in the military. Read More ›
The Department of Veterans Affairs (VA) announced in September that it will conduct a scientific assessment to determine if there is a relationship between per- and polyfluoroalkyl substances (PFAS) exposure during military service and kidney cancer among veterans. Read More ›
There is a “significant” link between toxic exposures during military service and the prevalence of lung cancer among veterans, according to a study presented at the International Association for the Study of Lung Cancer (IASLC)’s 2024 World Conference on Lung Cancer. Read More ›